<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9861">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05688670</url>
  </required_header>
  <id_info>
    <org_study_id>PRO00111671</org_study_id>
    <nct_id>NCT05688670</nct_id>
  </id_info>
  <brief_title>Regional Anesthesia Following Pediatric Cardiac Surgery</brief_title>
  <official_title>Pain Control With Regional Anesthesia Following Pediatric Cardiac Surgery: A Randomized Double-Blinded Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Society of Pediatric Anesthesia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Duke University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate pain control following pediatric cardiac surgery&#xD;
      with the use of local anesthesia via an ultrasound guided regional anesthetic technique&#xD;
      compared with surgeon delivered wound infiltration.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center, randomized, double blind investigation which will compare&#xD;
      postoperative pain control indices, functional recovery metrics and patient/parental&#xD;
      satisfaction for pediatric patients receiving an ultrasound guided regional anesthetic versus&#xD;
      surgeon delivered wound infiltration in children undergoing primary atrial and ventricular&#xD;
      septal defect repairs. Surgical and anesthesia care, with the exception of the technique of&#xD;
      local anesthetic administration, are not altered for study purposes. Subjects are randomized&#xD;
      1:1 to either bilateral Pecto-Intercostal Fascial Block and unilateral Rectus Sheath Block or&#xD;
      infiltration of the wound through the perioperative period. Both interventions will use an&#xD;
      equal volume of Ropivacaine 0.2% based on weight. Exploratory data will be collected for up&#xD;
      to 30 days postoperatively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2023</start_date>
  <completion_date type="Anticipated">March 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2024</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total amount of opioid medications administered</measure>
    <time_frame>Up to 12 hours after surgery</time_frame>
    <description>Postoperative opioid medication expressed in morphine equivalents per kilogram</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total amount of opioid medications administered</measure>
    <time_frame>12 to 24 hours after surgery</time_frame>
    <description>Postoperative opioid medication expressed in morphine equivalents per kilogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total amount of opioid medications administered</measure>
    <time_frame>24 to 48 hours after surgery</time_frame>
    <description>Postoperative opioid medication expressed in morphine equivalents per kilogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total amount of opioid medications administered</measure>
    <time_frame>Up to 48 hours after surgery</time_frame>
    <description>Postoperative opioid medication expressed in morphine equivalents per kilogram</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity as measured by Face, Legs, Activity, Cry, Consolability (FLACC) Scale</measure>
    <time_frame>within the first 12 hours after surgery</time_frame>
    <description>Face, Legs, Activity, Cry, Consolability (FLACC) Scale, 0-10. 0 no pain, 10 worst possible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity as measured by Face, Legs, Activity, Cry, Consolability (FLACC) Scale</measure>
    <time_frame>12 to 24 hours after surgery</time_frame>
    <description>Face, Legs, Activity, Cry, Consolability (FLACC) Scale, 0-10. 0 no pain, 10 worst possible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity as measured by Face, Legs, Activity, Cry, Consolability (FLACC) Scale</measure>
    <time_frame>24 to 48 hours after surgery</time_frame>
    <description>Face, Legs, Activity, Cry, Consolability (FLACC) Scale, 0-10. 0 no pain, 10 worst possible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity as measured by Numeric Rating Scale</measure>
    <time_frame>within the first 12 hours after surgery</time_frame>
    <description>Visual Analog Scale and Numeric Rating Scale, 0-10. 0 no pain, 10 worst possible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity as measured by Numeric Rating Scale</measure>
    <time_frame>12 to 24 hours after surgery</time_frame>
    <description>Visual Analog Scale and Numeric Rating Scale, 0-10. 0 no pain, 10 worst possible pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Intensity as measured by Numeric Rating Scale</measure>
    <time_frame>24 to 48 hours after surgery</time_frame>
    <description>Visual Analog Scale and Numeric Rating Scale, 0-10. 0 no pain, 10 worst possible pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Atrial Septal Defect</condition>
  <condition>Ventricular Septal Defect</condition>
  <condition>Pain, Procedural</condition>
  <arm_group>
    <arm_group_label>Regional Anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided blocks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wound Infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgeon-delivered wound infiltration</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Regional Anesthesia</intervention_name>
    <description>Bilateral pecto-intercostal fascial plane block (PIFB) and unilateral rectus sheath block (RSB) with Ropivacaine 0.2%</description>
    <arm_group_label>Regional Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Wound infiltration</intervention_name>
    <description>Surgeon-delivered wound infiltration with Ropivacaine 0.2%</description>
    <arm_group_label>Wound Infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.2% Injectable Solution</intervention_name>
    <description>Ropivacaine 1.5 mL/kg will be used for both interventions</description>
    <arm_group_label>Regional Anesthesia</arm_group_label>
    <arm_group_label>Wound Infiltration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Children less than 18 years old&#xD;
&#xD;
          2. Presenting for primary atrial septal defect or ventricular septal defect repair&#xD;
&#xD;
          3. Informed consent / assent provided&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients on opioid therapy at the time of surgery&#xD;
&#xD;
          2. History of sternotomy&#xD;
&#xD;
          3. Planned postoperative intubation&#xD;
&#xD;
          4. Current diagnosis of a chronic pain syndrome.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa M Einhorn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julia Hoang</last_name>
    <phone>919.681.9786</phone>
    <email>Julia.hoang@duke.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Hoang</last_name>
      <email>Julia.hoang@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Lisa M. Einhorn, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>January 9, 2023</study_first_submitted>
  <study_first_submitted_qc>January 9, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2023</study_first_posted>
  <last_update_submitted>March 29, 2023</last_update_submitted>
  <last_update_submitted_qc>March 29, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Regional anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Septal Defects</mesh_term>
    <mesh_term>Heart Septal Defects, Ventricular</mesh_term>
    <mesh_term>Heart Septal Defects, Atrial</mesh_term>
    <mesh_term>Pain, Procedural</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

